{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:29:58Z","timestamp":1791415798786,"version":"4.3.3"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/jtm\/tax025","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T20:14:32Z","timestamp":1489176872000},"source":"Crossref","is-referenced-by-count":15,"title":["A meta-analysis of the use of rifaximin to prevent travellers\u2019 diarrhoea"],"prefix":"10.1093","volume":"24","author":[{"given":"Qin Xiang","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin Yih Xian","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongju","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Venkatanarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwei Wuen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"key\n\t\t\t\t20171012104523_tax025-B1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1708-8305.2008.00203.x","article-title":"Gastrointestinal infection among international travelers globally","volume":"15","year":"2008","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t20171012104523_tax025-B2","first-page":"231","article-title":"Epidemiology of travelers\u2014diarrhea: details of a global survey","volume":"11","year":"2004","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t20171012104523_tax025-B3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/apt.13199","article-title":"Systematic review with meta\u2010analysis: post\u2010infectious irritable bowel syndrome after travellers' diarrhoea","volume":"41","year":"2015","journal-title":"Aliment Pharmacol Therapeutics"},{"key":"key\n\t\t\t\t20171012104523_tax025-B4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2014.17006","article-title":"Traveler\u2019s diarrhea: a clinical review","volume":"313","year":"2015","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012104523_tax025-B5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MOG.0000000000000133","article-title":"An update on travelers\u2019 diarrhea","volume":"31","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"key":"key\n\t\t\t\t20171012104523_tax025-B6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4269\/ajtmh.2009.80.609","article-title":"Global etiology of travelers\u2019 diarrhea: systematic review from 1973 to the present","volume":"80","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20171012104523_tax025-B7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-59-5-605","article-title":"The diarrhea of travelers to Mexico: summary of five-year study","volume":"59","year":"1963","journal-title":"Ann Internal Med"},{"key":"key\n\t\t\t\t20171012104523_tax025-B8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1056\/NEJM197804062981402","article-title":"Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Kenya","volume":"298","year":"1978","journal-title":"New Eng J Med"},{"key":"key\n\t\t\t\t20171012104523_tax025-B9","first-page":"ciu957.","article-title":"Antimicrobials increase travelers\u2019 risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012104523_tax025-B10","first-page":"67","article-title":"Rifaximin: in vitro and in vivo antibacterial activity\u2014a review","volume":"51(Suppl. 1)","year":"2005","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20171012104523_tax025-B11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/14787210.3.2.201","article-title":"Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections","volume":"3","year":"2005","journal-title":"Expert Rev Anti Infect Ther."},{"key":"key\n\t\t\t\t20171012104523_tax025-B12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000007297","article-title":"In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species","volume":"46","year":"2000","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20171012104523_tax025-B13","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s10620-013-2675-0","article-title":"The effect of rifaximin on gut flora and Staphylococcus resistance","volume":"58","year":"2013","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t20171012104523_tax025-B14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-2036.2010.04296.x","article-title":"Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers\u2019 diarrhoea","volume":"31","year":"2010","journal-title":"Aliment Pharmacol Therapeutics"},{"key":"key\n\t\t\t\t20171012104523_tax025-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","year":"1996","journal-title":"Control Clin Trials"},{"key":"key\n\t\t\t\t20171012104523_tax025-B16","doi-asserted-by":"crossref","first-page":"d5928.","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171012104523_tax025-B17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1708-8305.2010.00462.x","article-title":"randomized, double\u2010blind, placebo\u2010controlled study evaluating the efficacy and safety of rifaximin for the prevention of travelers' diarrhea in us military personnel deployed to incirlik air base, Incirlik, Turkey","volume":"17","year":"2010","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t20171012104523_tax025-B18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-142-10-200505170-00005","article-title":"A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea","volume":"142","year":"2005","journal-title":"Ann Internal Med"},{"key":"key\n\t\t\t\t20171012104523_tax025-B19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1708-8305.2009.00385.x","article-title":"Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico","volume":"17","year":"2010","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t20171012104523_tax025-B20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1708-8305.2011.00549.x","article-title":"Randomized, double\u2010blind, pilot study of rifaximin 550\u2009mg versus placebo in the prevention of travelers' diarrhea in mexico during the dry season","volume":"18","year":"2011","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t20171012104523_tax025-B21","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S1473-3099(13)70221-4","article-title":"Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20171012104523_tax025-B22","first-page":"51","article-title":"Pharmacokinetic study of rifaximin after oral administration in healthy volunteers","volume":"14","year":"1993","journal-title":"Int J Clin Pharmacol Res"},{"key":"key\n\t\t\t\t20171012104523_tax025-B23","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.00342-08","article-title":"Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemotherapy"},{"key":"key\n\t\t\t\t20171012104523_tax025-B24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ja.2014.106","article-title":"Rifaximin: beyond the traditional antibiotic activity","volume":"67","year":"2014","journal-title":"J Antibiotics"},{"key":"key\n\t\t\t\t20171012104523_tax025-B25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijantimicag.2014.01.026","article-title":"In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK","volume":"43","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171012104523_tax025-B26","first-page":"dkq345.","article-title":"Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system","year":"2010","journal-title":"J Antimicrob Chemotherapy"},{"key":"key\n\t\t\t\t20171012104523_tax025-B27","first-page":"979","article-title":"Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin","volume":"12","year":"1985","journal-title":"Drugs Under Exp Clin Res"},{"key":"key\n\t\t\t\t20171012104523_tax025-B28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/516303","article-title":"Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years","volume":"26","year":"1998","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jtm\/article-pdf\/24\/5\/tax025\/17013846\/tax025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T16:03:02Z","timestamp":1568908982000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/tax025\/3820940\/A-metaanalysis-of-the-use-of-rifaximin-to-prevent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,12]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/tax025","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,5,12]]}}}